The United States Postal Service has been at the heart of a bitter partisan divide over the last few months of COVID-19 and the U.S. election season.
Prominent Democratic politicians have alleged that recent reforms and administrative changes ushered by recently appointed Postmaster General Louis DeJoy have led to widespread service delays across the country. At the same time, President Donald Trump has repeatedly signaled to the media that he is against emergency funding injections sought by Democrats and the USPS, which is expected to face extended difficulties in the coming months due to the combined pressure of mail-in ballots and COVID-19 disruptions.
In a statement published yesterday, DeJoy said that the USPS would be suspending some of the reforms in question until after the election. But while the service's role in the election is on the forefront of many Americans' minds, patients and medical professional organizations alike have voiced immediate and long-term concerns about the 1.2 billion prescription drug shipments handled by the USPS annually.
Print Page
Email to a Friend